The slip
PARKINSON RECEIPTno. 4346
20 Oct 2026, 15:27 UTCdopamine neurons, braak
predictionNFIA in dopamine neurons tracks Braak Lewy-body stage
registered58a5bf6a121dea25
discovery-0.28 p=0.471 n=9
replication-0.11 p=0.773 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.28, p 0.471)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT73f522315d4ef0694e54b5c7…
follows e0ec92fa0116…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 4346: NFIA in dopamine neurons, braak
- power
- full sample -0.09 (p 0.728, n 18), 95% CI -0.53 to +0.40. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.11 (p 0.652, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.12 (p 0.627, n 18). could be the mix.
- skeptic
- leave-one-out range -0.19 to +0.05, sign flips 3; without severely affected donors -0.09 (p 0.728, n 18). fragile.
- cell type
- strongest in microglia: -0.65 (p 0.0037, n 18) vs -0.09 in dopamine neurons. proposing microglia.
- axis
- no measure beats "tracks Braak Lewy-body stage" for NFIA in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up NFIA · microglia · braak: substantia nigra, an independent cohort (already registered)